Home/Filings/4/0001104659-21-030948
4//SEC Filing

Schranz Jennifer 4

Accession 0001104659-21-030948

CIK 0001641640other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 7:40 PM ET

Size

4.8 KB

Accession

0001104659-21-030948

Insider Transaction Report

Form 4
Period: 2021-02-28
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2021-02-28$2.39/sh33$7939,125 total
Footnotes (1)
  • [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001735382

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:40 PM ET
Size
4.8 KB